• Paphatchaya Suwannachote Department of Medical Technology, Chonburi Hospital
  • Wacharee Charoonwach Department of Medical Technology, Chonburi Hospital
  • Khetsaraporn Phutphakwan Faculty of Allied Health Sciences, Burapha University
  • Pattaraporn Jamrassri Faculty of Allied Health Sciences, Burapha University
  • Doungpat Khumsakulthai Faculty of Allied Health Sciences, Burapha University
  • Natthapaninee Thanomsridetchai Faculty of Allied Health Sciences, Burapha University


Candida spp, Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS), Clinical Specimens


Candida spp. is an important opportunistic fungus that can infect mainly in immunocompromised hosts, especially in HIV infected patients. Therefore, the accurate and rapid identification of Candida spp. is influential in treatment decision and may reduce the rate of antifungal drug resistance. The conventional methods of fungal identification in the clinical diagnostic laboratory are complicated and time-consuming. Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) is one of rapid and reliable fungal diagnostic tools used nowadays. In this study, we evaluated eighty-five isolates of Candida spp. form clinical specimens by using MALDI-TOF MS technique compared to the conventional methods, including Germ tube test, Chlamydospore formation test and CHROMagar.The results demonstrated that MALDI-TOF MS technique can be used to differentiate Candida spp. from the clinical specimen especially for Candida glabrata, C. orthopsilosis, C. rugosa, Trichosporon asahii, and T. inkin which could not be previously identified by using conventional methods. From our study it can be concluded that MALDI-TOF MS technique is one of the accurate tools and appropriate to increase the efficiency of Candida identification.


Download data is not yet available.


Schmiedel, Y., and Zimmerli, S. (2016). Common invasive fungal diseases: An overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia. Swiss Med Wkly, 146, w14281.

Tan, T. Y., Hsu, L. Y., Alejandria, M. M., Chaiwarith, R., Chinniah, T., Chayakulkeeree, M., Choudhury, S., Chen, Y. H., Shin, J. H., Kiratisin, P., Mendoza, M., Prabhu, K., Supparatpinyo, K., Tan, A. L., Phan, X. T., Tran, T. T., Nguyen, G. B., Doan, M. P., Huynh, V. A., Nguyen, S. M., Tran, T. B., and Van Pham, H. (2016). Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region. Med Mycol, 54(5), 471-477.

Moriyama, B., Gordon, L. A., McCarthy, M., Henning, S. A., Walsh, T. J., and Penzak, S. R. (2014). Emerging drugs and vaccines for candidemia. Mycoses, 57(12), 718-733.

Whaley, S. G., Berkow, E. L., Rybak, J. M., Nishimoto, A. T., Barker, K. S., and Rogers, P. D. (2017). Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species. Front Microbiol, 7, 2173.

Terças, A. L., Marques, S. G., Moffa, E. B., Alves, M. B., de Azevedo, C. M., Siqueira, W. L., and Monteiro, C. A. (2017). Antifungal Drug Susceptibility of Candida Species Isolated from HIV-Positive Patients Recruited at a Public Hospital in São Luís, Maranhão, Brazil. Front Microbiol, 8, 298.

Lindberg, E., Hammarström, H., Ataollahy, N., and Kondori, N. (2019). Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia. Sci Rep, 9(1), 3838.

Wu, P. F., Liu, W. L., Hsieh, M. H., Hii, I. M., Lee, Y. L., Lin, Y. T., Ho, M. W., Liu, C. E., Chen, Y. H., and Wang, F. D. (2017). Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients. Emerg Microbes Infect, 6(10), e87.

Bonfietti, L. X., Martins, M. A., Szeszs, M. W., Pukiskas, S. B. S., Purisco, S. U., Pimentel, F. C., Pereira, G. H., Silva, D. C., Oliveira, L., and Melhem, M. S. C. (2012). Prevalence, distribution and antifungal susceptibility profiles of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis bloodstream isolates. J Med Microbiol, 61(7), 1003-1008.

Posteraro, B., Efremov, L., Leoncini, E., Amore, R., Posteraro, P., Ricciardi, W., and Sanguinetti, M. (2015) Are the Conventional Commercial Yeast Identification Methods Still Helpful in the Era of New Clinical Microbiology Diagnostics? A Meta-Analysis of Their Accuracy. J Clin Microbiol, 53(8), 2439-2450.

Patel R. (2019). A Moldy Application of MALDI: MALDI-ToF Mass Spectrometry for Fungal Identification. J Fungi (Basel), 5(1), 4.

Ali R. Hameed, Sabah M. Ali, and Luma T. Ahmed. (2018). Biological study of Candida species virulence Factor. International Journal of Advanced Research in Engineering & Technology, 1(4), 8-16.

Aslani, N., Janbabaei, G., Abastabar, M., Meis, J. F., Babaeian, M., Khodavaisy, S., Boekhout, T., and Badali H. (2018). Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry. BMC Infect Dis, 18(1), 24.

Go, S. E., Lee, K. J., Kim, Y., Choi, J. K., Kim, Y. J., and Lee, D. G. (2018). Catheter-Related Trichosporon asahii Bloodstream Infection in a Neutropenic Patient with Myelodysplastic Syndrome. Infect Chemother, 50(2), 138-143.

Sow, D., Fall, B., Ndiaye, M., Ba, B. S., Sylla, K., Tine, R., Lô, A. C., Abiola, A., Wade, B., Dieng, T., Dieng, Y., Ndiaye, J. L., Hennequin, C., Gaye, O., and Faye, B. (2015). Usefulness of MALDI-TOF Mass Spectrometry for Routine Identification of Candida Species in a Resource-

Poor Setting. Mycopathologia, 180(3-4), 173-179.

Yu, S. Y., Guo, L. N., Xiao, M., Kudinha, T., Kong, F., Wang, H., Cheng, J. W., Zhou, M. L., Xu, H., and Xu, Y. C. (2018). Trichosporon dohaense, a rare pathogen of human invasive infections, and literature review. Infect Drug Resist, 11, 1537-1547.

Neppelenbroek, K. H., Seó, R. S., Urban, V. M., Silva, S., Dovigo, L. N., Jorge, J. H., and Campanha, N. H. (2014). Identification of Candida species in the clinical laboratory: A review of conventional, commercial, and molecular techniques. Oral Dis, 20(4), 329-344.

Ghelardi, E., Pichierri, G., Castagna, B., Barnini, S., Tavanti, A., and Campa, M. (2008). Efficacy of Chromogenic Candida Agar for isolation and presumptive identification of pathogenic yeast species. Clin Microbiol Infect, 14(2), 141-147.

Eraso, E., Sahand, I. H., Villar-Vidal, M., Marcos, C., Dolores Moragues, M., Madariaga, L., Pontón, J., and Quindós, G. (2006). Usefulness of Candida ID2 agar for the presumptive identification of Candida dubliniensis. Med Mycol, 44(7), 611-615.

Maaroufi, Y., Heymans, C., De Bruyne, J. M., Duchateau, V., Rodriguez-Villalobos, H., Aoun, M., and Crokaert, F. (2003). Rapid detection of Candida albicans in clinical blood samples by using a TaqMan-based PCR assay. J Clin Microbiol, 41(7), 3293-3298.




How to Cite

Suwannachote, P. ., Charoonwach, W. ., Phutphakwan, K. ., Jamrassri, P. ., Khumsakulthai, D. ., & Thanomsridetchai, N. . (2022). IDENTIFICATION OF CANDIDA SPP. FROM CLINICAL SPECIMENS BY MATRIX-ASSISTED LASER DESORPTION/IONIZATION TIME-OF-FLIGHT MASS SPECTROMETRY (MALDI-TOF MS). Srinakharinwirot University Journal of Sciences and Technology, 14(28, July-December), 105–116. Retrieved from